J Sternon
Impact in
- Food Science top 5%
- Salmonella and Campylobacter epidemiology
- Endocrinology top 10%
- Vibrio bacteria research studies
Papers in
- Pharmacology 10
- Antibiotics Pharmacokinetics and Efficacy 3
- Cholinesterase and Neurodegenerative Diseases 3
-
- Pneumonia and Respiratory Infections 5
- Co-authors
- J.P. Butzler (2 shared papers)P. Dekeyser (1 shared paper)Jean Ducobu (3 shared papers)G Delespesse (3 shared papers)Bernard Kennès (1 shared paper)Camélia Rossi (2 shared papers)Edmond Balasse (1 shared paper)J. P. Butzler (2 shared papers)
In The Last Decade
J Sternon
46 papers receiving 261 citations
Peers
Comparison fields: 5 of 73
- Food Science 180
- Endocrinology 35
- Infectious Diseases 113
- Biotechnology 48
- Animal Science and Zoology 28
Countries citing papers authored by J Sternon
This map shows the geographic impact of J Sternon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Sternon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Sternon more than expected).
Fields of papers citing papers by J Sternon
This network shows the impact of papers produced by J Sternon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Sternon. The network helps show where J Sternon may publish in the future.
Co-authors
The 25 scholars most cited alongside J Sternon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 203 | |
| 2 | 1978 | 17 | |
| 3 | [Rimonabant (Acomplia), specific inhibitor of the endocannabinoid system]. | 2005 | 12 |
| 4 | 1967 | 11 | |
| 5 | 1995 | 7 | |
| 6 | 1976 | 6 | |
| 7 | [Salmonellosis and neoplasia. Apropos of 23 cases]. | 1969 | 5 |
| 8 | [Malignant thymoma, myasthenia, thyroiditis, Gougerot-Sjögren syndrome and alveolo-capillary block. Apropos of a case]. | 1968 | 5 |
| 9 | 1971 | 4 | |
| 10 | [Third and fourth generation fluoroquinolones]. | 2001 | 3 |
| 11 | 1970 | 3 | |
| 12 | [Dopaminergic agonists in the treatment of Parkinson's disease]. | 2000 | 3 |
| 13 | 1975 | 2 | |
| 14 | Les glitazones (thiazolidinediones) | 2000 | 2 |
| 15 | 1995 | 2 | |
| 16 | 1974 | 2 | |
| 17 | 1990 | 2 | |
| 18 | 1975 | 2 | |
| 19 | [Insulin analogues: place of detemir (Levemir)]. | 2006 | 2 |
| 20 | [Omega-3 fatty acids and cardiovascular diseases]. | 2006 | 2 |
About J Sternon
J Sternon is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 53 papers that have together received 330 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Liver Diseases and Immunity (3 papers), Hormonal and reproductive studies (2 papers), Vibrio bacteria research studies (2 papers), Myasthenia Gravis and Thymoma (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Food Science (180 citations), Endocrinology (35 citations), Infectious Diseases (113 citations), Biotechnology (48 citations) and Animal Science and Zoology (28 citations). J Sternon has collaborated with scholars based in Belgium, France and Germany. Frequent co-authors include J.P. Butzler, P. Dekeyser, Jean Ducobu, G Delespesse, Bernard Kennès, Camélia Rossi, Edmond Balasse, J. P. Butzler, K Blot and E. G. M. Couturier. Their work appears in journals such as Acta Clinica Belgica, Endoscopy, The Lancet, The American Journal of Cardiology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.